The Valley Desk

NCT00911898 · Interventional trial

A Study of MM-111 in Patients With Advanced, Refractory Her2 Amplified, Heregulin Positive Cancers

Overall registry status Completed

Phase 1

Conditions Her2 Amplified Solid Tumors, Metastatic Breast Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov